
A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds
|
|||||
![]() A biotechnology company creating targeted antibacterial and microbiome treatments aided by gene editing is raising $35 million in new venture funds. . . . → Read More: Precision Antibacterial Company Raises $35M in New Funds ![]() Early results from a clinical trial show an experimental gene transfer therapy largely reduces painful events from sickle cell disease for one to two years. . . . → Read More: Trial Shows Gene Therapy Results with Sickle Cell Disease ![]() Initial results from a clinical trial show non-Hodgkin lymphoma patients receiving low doses of gene-edited T-cells achieve a clinical response, but with some adverse effects. . . . → Read More: Early Trial Data Show Crispr Cancer Therapy Response ![]() A clinical trial is set to begin assessing an electronic capsule designed to detect and transmit images from the gut to detect early cancer-causing polyps. . . . → Read More: Trial Set for Ingested Colon Cancer Detection Capsule ![]() National Institute of Mental Health is funding a clinical trial to evaluate a home-based mobile app that works online with a clinician to treat depression. . . . → Read More: Small Biz Grant Funds Mental Health App Clinical Trial ![]() A software company is partnering with a psychologist to explore virtual reality working with mindfulness for relieving pain in cancer patients. . . . → Read More: Virtual Reality Studied for Chronic Cancer Pain ![]() A clinical trial is underway testing a therapy for opioid use disorder that places a treatment drug pellet under the skin lasting for 12 weeks. . . . → Read More: Trial Begins for Skin-Implanted Addiction Therapy ![]() A California state agency is helping fund a clinical trial testing an immunotherapy combined with a cancer-killing virus to treat solid tumor cancers. . . . → Read More: State Grant Funds Virus-Immunotherapy Cancer Trial ![]() First results from two clinical trials testing the safety of natural killer cell therapies show responses by patients with some forms of blood-related cancers. . . . → Read More: Early Trials Show Responses for Some Blood Cancers ![]() A clinical trial is underway assessing a genetically edited oral drug designed to remove E. coli in the gut, a danger for patients with blood-related cancers. . . . → Read More: Trial Begins Testing Crispr Gut Microbiome Therapy |
|||||
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |